Dr Reddys Laboratories RDY
NYSE RDY
$11.84 -0.04 (-0.34%)
As of: Sep 9, 2026 · 2:37 PM EDT

Dr Reddys Laboratories (RDY) Change in Taxes (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Change in Taxes of -$20.5 million for Q2 2026, up 68.37% on a QoQ basis from -$64.9 million in Q3 2025, and up 44.93% year-over-year from -$14.2 million in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Change in Taxes (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Change in Taxes for 17 years, with the latest figure at -$20.5 million in Q2 2026.

  • On a quarterly basis, Change in Taxes rose 44.93% year-over-year to -$20.5 million in Q2 2026; TTM through Jun 2026 was -$208.9 million, a 0.18% change from a year earlier, with the FY2026 full-year figure at -$144.0 million, up 38.46% from the prior year.
  • Change in Taxes was -$20.5 million for Q2 2026 at Dr Reddys Laboratories, up from -$64.9 million in the prior quarter.
  • The five-year high for Change in Taxes was -$14.8 million in Q2 2022, with the low at -$86.2 million in Q3 2024.
  • Average Change in Taxes over 5 years is -$44.8 million, with a median of -$40.6 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2026: Change in Taxes slumped 150.12% in 2023, then surged 44.93% in 2026.
  • Over 5 years, Change in Taxes stood at -$28.9 million in 2022, then plunged by 150.12% to -$72.4 million in 2023, then retreated by 19.14% to -$86.2 million in 2024, then gained by 24.79% to -$64.9 million in 2025, then soared by 68.37% to -$20.5 million in 2026.
  • The last three Change in Taxes figures came in at -$20.5 million (Q2 2026), -$64.9 million (Q3 2025), and -$37.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn -
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn 40.90 Mn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn -20.51 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn -
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -208,000.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -1.77 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn -
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.51 Mn
Sep 30, 2025 -64.86 Mn
Jun 30, 2025 -37.25 Mn
Sep 30, 2024 -86.24 Mn
Jun 30, 2024 -18.35 Mn
Mar 31, 2024 -66.64 Mn
Dec 31, 2023 -72.38 Mn
Sep 30, 2023 -73.82 Mn
Jun 30, 2023 -29.02 Mn
Mar 31, 2023 -44.99 Mn
Dec 31, 2022 -28.94 Mn
Sep 30, 2022 -43.91 Mn
Jun 30, 2022 -14.77 Mn
Mar 31, 2022 -25.31 Mn
Dec 31, 2021 -26.63 Mn
Sep 30, 2021 -31.76 Mn
Jun 30, 2021 -16.08 Mn
Mar 31, 2021 -31.28 Mn
Dec 31, 2020 -18.39 Mn
Sep 30, 2020 -16.02 Mn